鉴定和描述一种新型的CASR突变,导致家族性低性高血症
Chien-Ming Lin1, Yi-Xuan Ding1, Shih-Ming Huang2
1Department of Pediatrics, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Frontiers in endocrinology
|March 15, 2024
概括
一种新的感受受体 (CASR) I554N突变导致家族性低性血过高 (FHH). 这种突变损害了CASR稳定性和结合,但仿药治疗可以纠正这些影响.
科学领域:
- 内分泌学 在内分泌学.
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 家庭性低性高血症 (FHH) 通常是由感受受体 (CASR) 基因中的异性突变引起的.
- 特定的CASR突变对仿疗法反应的功能影响需要进一步阐明.
研究的目的:
- 在患有FHH的患者中识别和功能性地表征一种新的CASR突变.
- 调查突变致病性背后的分子机制.
- 评估仿药在纠正突变引起的功能缺陷方面的有效性.
主要方法:
- 桑格对CASR,GNA11和AP2S1基因进行测序.
- 在模拟中预测蛋白质功能.
- 在体外研究包括免疫阻塞,免疫光,循环赫西米德追逐和Ca2+检测测定.
- 半最大有效度 (EC50) 分析,以测量形反应.
主要成果:
- 在试验中发现了一种新异构的CASR I554N误解突变.
- 该CASR I554N突变降低了蛋白质稳定性,降低了结合亲和力,并削弱了细胞内信号传输.
- 模仿药在体外证明了对CASR I554N突变的功能缺陷的纠正作用.
结论:
- 新的CASR I554N突变是致病性的,通过破坏受体的稳定性并降低其敏感性来引起FHH.
- 治疗性仿药可以有效地纠正与这种特定的CASR突变相关的功能异常.
更多相关视频
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
33.7K
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
3.1K
相关概念视频
Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
